FDA
approval
· 2021-01-21
FDA Approved: CABENUVA — Original Application (ViiV Healthcare Company)
Summary
The FDA approved CABENUVA (cabotegravir and rilpivirine) as the original approval for a long-acting injectable regimen to treat HIV-1 infection in adults who ar…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
ORIG AP for CABENUVA (CABOTEGRAVIR AND RILPIVIRINE)